The price has held pretty well today considering the news of EBITDA revision, debt uncertainty and the long suspension, it was looking ugly at 6.2 but the recovery up to 7.5 is a little more comforting.
I suspect it will slowly edge up over the weeks to come on speculation of an agreement or takeover like it had done before the suspension.
